IDEAYA Biosciences Inc
NASDAQ:IDYA
Cash Flow Statement
Cash Flow Statement
IDEAYA Biosciences Inc
Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||
Net Income |
(34)
|
(38)
|
(42)
|
(40)
|
(42)
|
(44)
|
(46)
|
(40)
|
(35)
|
(31)
|
(30)
|
(37)
|
(50)
|
(55)
|
(66)
|
(53)
|
(59)
|
(68)
|
(74)
|
(103)
|
(113)
|
(129)
|
|
Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
|
Stock-Based Compensation |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
17
|
18
|
0
|
|
Other Non-Cash Items |
4
|
4
|
5
|
1
|
2
|
2
|
3
|
3
|
4
|
6
|
7
|
9
|
10
|
11
|
11
|
12
|
11
|
10
|
9
|
8
|
7
|
5
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
2
|
1
|
(0)
|
(1)
|
(0)
|
2
|
(0)
|
94
|
84
|
76
|
73
|
(25)
|
(18)
|
(19)
|
(16)
|
(41)
|
(42)
|
(39)
|
(46)
|
(22)
|
(12)
|
(10)
|
|
Cash from Operating Activities |
(28)
N/A
|
(32)
-15%
|
(36)
-14%
|
(38)
-5%
|
(39)
-3%
|
(39)
+1%
|
(42)
-9%
|
58
N/A
|
55
-5%
|
51
-8%
|
52
+1%
|
(51)
N/A
|
(56)
-10%
|
(62)
-11%
|
(69)
-11%
|
(80)
-17%
|
(87)
-8%
|
(95)
-9%
|
(109)
-14%
|
(115)
-6%
|
(115)
0%
|
(131)
-14%
|
|
Investing Cash Flow | |||||||||||||||||||||||
Capital Expenditures |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(4)
|
|
Other Items |
(61)
|
25
|
51
|
6
|
4
|
(11)
|
8
|
(137)
|
(146)
|
(119)
|
(199)
|
(72)
|
(67)
|
(122)
|
(58)
|
(20)
|
(30)
|
11
|
(125)
|
(55)
|
(156)
|
(532)
|
|
Cash from Investing Activities |
(63)
N/A
|
23
N/A
|
49
+114%
|
5
-90%
|
2
-54%
|
(12)
N/A
|
7
N/A
|
(138)
N/A
|
(146)
-6%
|
(121)
+17%
|
(201)
-67%
|
(74)
+63%
|
(70)
+6%
|
(124)
-78%
|
(61)
+51%
|
(24)
+62%
|
(33)
-42%
|
8
N/A
|
(127)
N/A
|
(57)
+55%
|
(158)
-179%
|
(536)
-238%
|
|
Financing Cash Flow | |||||||||||||||||||||||
Net Issuance of Common Stock |
105
|
0
|
51
|
51
|
51
|
51
|
94
|
102
|
109
|
151
|
72
|
152
|
145
|
104
|
89
|
98
|
97
|
99
|
290
|
222
|
363
|
709
|
|
Other |
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
105
N/A
|
(1)
N/A
|
51
N/A
|
50
-1%
|
51
+0%
|
51
+2%
|
94
+84%
|
122
+29%
|
129
+6%
|
171
+33%
|
92
-46%
|
152
+65%
|
145
-4%
|
104
-28%
|
89
-15%
|
98
+10%
|
97
0%
|
99
+2%
|
290
+192%
|
222
-23%
|
363
+63%
|
709
+95%
|
|
Change in Cash | |||||||||||||||||||||||
Net Change in Cash |
15
N/A
|
(10)
N/A
|
63
N/A
|
17
-73%
|
14
-22%
|
0
-99%
|
59
+34 859%
|
42
-29%
|
38
-10%
|
101
+167%
|
(57)
N/A
|
27
N/A
|
20
-26%
|
(81)
N/A
|
(41)
+49%
|
(7)
+84%
|
(23)
-260%
|
12
N/A
|
54
+355%
|
51
-7%
|
89
+76%
|
42
-53%
|
|
Free Cash Flow | |||||||||||||||||||||||
Free Cash Flow |
(29)
N/A
|
(34)
-16%
|
(39)
-14%
|
(40)
-2%
|
(41)
-3%
|
(39)
+4%
|
(43)
-9%
|
58
N/A
|
55
-5%
|
50
-9%
|
50
+0%
|
(53)
N/A
|
(58)
-10%
|
(64)
-9%
|
(72)
-13%
|
(85)
-17%
|
(91)
-7%
|
(98)
-9%
|
(111)
-13%
|
(116)
-5%
|
(118)
-1%
|
(135)
-15%
|